<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04698447</url>
  </required_header>
  <id_info>
    <org_study_id>Natural Supplement CitraVes</org_study_id>
    <nct_id>NCT04698447</nct_id>
  </id_info>
  <brief_title>The Role of a Natural Product, Containing Nanovesicles From Citrus Limon (L.) Juice, on Different CV Risk Factors</brief_title>
  <official_title>Effects of the Natural Supplement CitraVes Containing Nanovesicles Delivered From Citrus Limon (L.) Juice on Cardio-metabolic Risk Factors in Subjects With Metabolic Syndrome</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Palermo</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Palermo</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Clinical trial about beneficial effects of natural supplement in a spray-dried formulation,&#xD;
      citraVes™, obtained from Citrus Limon (L.) juice on general body health.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is one randomized, double-blind, placebo-controlled study. The aim of the present study&#xD;
      is to investigate the role of a natural product, citraVes™ on several cardiovascular risk&#xD;
      factors.&#xD;
&#xD;
      The research hypothesis is to evaluate whether this natural supplement containing&#xD;
      nanovesicles delivered from Citrus Limon (L.) juice (Navhetec S.R.L., Palermo, Italy) may&#xD;
      improve different cardio-metabolic parameters in subjects with the metabolic syndrome. All&#xD;
      subjects will be evaluated at baseline, after 1 month and after 3 and 6 months of&#xD;
      supplementation with natural product or placebo.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">March 28, 2019</start_date>
  <completion_date type="Anticipated">February 2021</completion_date>
  <primary_completion_date type="Actual">June 19, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>placebo-controlled study</intervention_model_description>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
    <masking_description>double-blind study</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Change from Baseline in Plasma Lipids in Healthy Subjects</measure>
    <time_frame>3 months</time_frame>
    <description>Effect of natural supplement containing nanovesicles from Citrus Limon (L.) juice on low-density lipoprotein cholesterol (LDL-C), total cholesterol, triglycerides, and high-density lipoprotein cholesterol (HDL-C) (mmol/l).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from Baseline in Plasma Lipids in Subjects with Metabolic Syndrome</measure>
    <time_frame>6 months</time_frame>
    <description>Effect of natural supplement containing nanovesicles from Citrus Limon (L.) juice on low-density lipoprotein cholesterol (LDL-C), total cholesterol, triglycerides, and high-density lipoprotein cholesterol (HDL-C) (mmol/l).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change from Baseline in Waist Circumference in Healthy Subjects</measure>
    <time_frame>3 months</time_frame>
    <description>Effect of natural supplement containing nanovesicles from Citrus Limon (L.) juice on waist circumference (cm).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from Baseline in Waist Circumference in Subjects with Metabolic Syndrome</measure>
    <time_frame>6 months</time_frame>
    <description>Effect of natural supplement containing nanovesicles from Citrus Limon (L.) juice on waist circumference (cm).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from Baseline in Body Mass Index (BMI) in Healthy Subjects</measure>
    <time_frame>3 months</time_frame>
    <description>Effect of natural supplement containing nanovesicles from Citrus Limon (L.) juice on body weight (kg) and height (m) that will be combined to report BMI in kg/m^2.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from Baseline in Body Mass Index (BMI) in Subjects with Metabolic Syndrome</measure>
    <time_frame>6 months</time_frame>
    <description>Effect of natural supplement containing nanovesicles from Citrus Limon (L.) juice on body weight (kg) and height (m) that will be combined to report BMI in kg/m^2.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from Baseline in Glycemia in Healthy Subjects</measure>
    <time_frame>3 months</time_frame>
    <description>Effect of natural supplement containing nanovesicles from Citrus Limon (L.) juice on plasma glycemia (mmol/l).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from Baseline in Glycemia in Subjects with Metabolic Syndrome</measure>
    <time_frame>6 months</time_frame>
    <description>Effect of natural supplement containing nanovesicles from Citrus Limon (L.) juice on plasma glycemia (mmol/l).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from Baseline in Glycated Haemoglobin in Healthy Subjects</measure>
    <time_frame>3 months</time_frame>
    <description>Effect of natural supplement containing nanovesicles from Citrus Limon (L.) juice on glycated haemoglobin (HbA1c) (%).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from Baseline in Glycated Haemoglobin in Subjects with Metabolic Syndrome</measure>
    <time_frame>6 months</time_frame>
    <description>Effect of natural supplement containing nanovesicles from Citrus Limon (L.) juice on glycated haemoglobin (HbA1c) (%).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from Baseline in Subclinical Atherosclerosis in Subjects with Metabolic Syndrome</measure>
    <time_frame>6 months</time_frame>
    <description>Effect of natural supplement containing nanovesicles from Citrus Limon (L.) juice on subclinical atherosclerosis assessed by carotid intima-media thickness (CIMT) (mm).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from Baseline in Plasma Cytokines in Subjects with Metabolic Syndrome</measure>
    <time_frame>6 months</time_frame>
    <description>Effect of natural supplement containing nanovesicles from Citrus Limon (L.) juice on plasma cytokines (inflammatory markers) (pg/ml), that will be assessed using available enzyme-linked immunosorbent assay (ELISA) kits.</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">60</enrollment>
  <condition>Metabolic Syndrome</condition>
  <condition>Healthy Volunteers</condition>
  <arm_group>
    <arm_group_label>Dietary Supplement blinded</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>20 subjects with the metabolic syndrome receiving natural supplement containing nanovesicles delivered from Citrus Limon (L.) juice (1000 mg/day)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo blinded</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>20 subjects with the metabolic syndrome receiving placebo (without any active ingredients)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Dietary Supplement open-label</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>20 healthy volunteers receiving natural supplement containing nanovesicles delivered from Citrus Limon (L.) juice (1000 mg/day)</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Natural supplement containing nanovesicles delivered from Citrus Limon (L.) juice_MetS</intervention_name>
    <description>20 eligible subjects with the metabolic syndrome (MetS) will take natural supplement containing a spray-dried formulation of citraVes™, directly in the mouth, without water, to be dissolved preferably under the tongue, at a stable dose of one sachet a day (1000 mg/day) for 6 months and as add-on therapy to the ongoing treatment, maintained at fixed doses for the entire study.</description>
    <arm_group_label>Dietary Supplement blinded</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Placebo (without any active ingredients)</intervention_name>
    <description>20 eligible subjects with the metabolic syndrome will take placebo in a spray-dried formulation (without any active ingredients) directly in the mouth, without water, to be dissolved preferably under the tongue, at a stable dose of one sachet a day for 6 months, as add-on therapy to the ongoing treatment, maintained at fixed doses for the entire study.</description>
    <arm_group_label>Placebo blinded</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Natural supplement containing nanovesicles delivered from Citrus Limon (L.) juice_HS</intervention_name>
    <description>20 eligible healthy subjects (HS) will take natural supplement containing a spray-dried formulation of citraVes™, directly in the mouth, without water, to be dissolved preferably under the tongue, at a stable dose of one sachet a day (1000 mg/day) for 6 months, maintained at fixed doses for the entire study.</description>
    <arm_group_label>Dietary Supplement open-label</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  men and women &gt; 18 years old;&#xD;
&#xD;
          -  body mass index (BMI) &gt; 25 kg/m²;&#xD;
&#xD;
          -  subjects who are able to swallow;&#xD;
&#xD;
          -  subjects who are willing to participate in the study and therefore, to sign informed&#xD;
             consent prior to any study procedure;&#xD;
&#xD;
          -  the inclusion criteria for patients with MetS was also the diagnosis of MetS, as&#xD;
             defined by international consensus [Alberti KG, et al. Circulation. 2009; 120:1640-5].&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  pregnancy or the willingness to become pregnant;&#xD;
&#xD;
          -  severe renal or hepatic impairment;&#xD;
&#xD;
          -  known severe infections (such as HIV, HBV, HCV)&#xD;
&#xD;
          -  any neoplasms;&#xD;
&#xD;
          -  the exclusion criteria for healthy volunteers were also diagnosis of any one of the&#xD;
             following diseases: hypertension, diabetes mellitus, dyslipidaemia or metabolic&#xD;
             diseases.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Giuseppe Montalto, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital of Palermo, Palermo, Italy</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University Hospital of Palermo</name>
      <address>
        <city>Palermo</city>
        <zip>90127</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <reference>
    <citation>Martínez-Abundis E, Méndez-Del Villar M, Pérez-Rubio KG, Zuñiga LY, Cortez-Navarrete M, Ramírez-Rodriguez A, González-Ortiz M. Novel nutraceutic therapies for the treatment of metabolic syndrome. World J Diabetes. 2016 Apr 10;7(7):142-52. doi: 10.4239/wjd.v7.i7.142. Review.</citation>
    <PMID>27076875</PMID>
  </reference>
  <reference>
    <citation>Corrado C, Raimondo S, Chiesi A, Ciccia F, De Leo G, Alessandro R. Exosomes as intercellular signaling organelles involved in health and disease: basic science and clinical applications. Int J Mol Sci. 2013 Mar 6;14(3):5338-66. doi: 10.3390/ijms14035338.</citation>
    <PMID>23466882</PMID>
  </reference>
  <reference>
    <citation>Lakkaraju A, Rodriguez-Boulan E. Itinerant exosomes: emerging roles in cell and tissue polarity. Trends Cell Biol. 2008 May;18(5):199-209. doi: 10.1016/j.tcb.2008.03.002. Epub 2008 Apr 7. Review.</citation>
    <PMID>18396047</PMID>
  </reference>
  <reference>
    <citation>Wang B, Zhuang X, Deng ZB, Jiang H, Mu J, Wang Q, Xiang X, Guo H, Zhang L, Dryden G, Yan J, Miller D, Zhang HG. Targeted drug delivery to intestinal macrophages by bioactive nanovesicles released from grapefruit. Mol Ther. 2014 Mar;22(3):522-534. doi: 10.1038/mt.2013.190. Epub 2013 Aug 13.</citation>
    <PMID>23939022</PMID>
  </reference>
  <reference>
    <citation>Ju S, Mu J, Dokland T, Zhuang X, Wang Q, Jiang H, Xiang X, Deng ZB, Wang B, Zhang L, Roth M, Welti R, Mobley J, Jun Y, Miller D, Zhang HG. Grape exosome-like nanoparticles induce intestinal stem cells and protect mice from DSS-induced colitis. Mol Ther. 2013 Jul;21(7):1345-57. doi: 10.1038/mt.2013.64. Epub 2013 Jun 11.</citation>
    <PMID>23752315</PMID>
  </reference>
  <reference>
    <citation>Raimondo S, Naselli F, Fontana S, Monteleone F, Lo Dico A, Saieva L, Zito G, Flugy A, Manno M, Di Bella MA, De Leo G, Alessandro R. Citrus limon-derived nanovesicles inhibit cancer cell proliferation and suppress CML xenograft growth by inducing TRAIL-mediated cell death. Oncotarget. 2015 Aug 14;6(23):19514-27.</citation>
    <PMID>26098775</PMID>
  </reference>
  <reference>
    <citation>Li C, Schluesener H. Health-promoting effects of the citrus flavanone hesperidin. Crit Rev Food Sci Nutr. 2017 Feb 11;57(3):613-631. Review.</citation>
    <PMID>25675136</PMID>
  </reference>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>December 27, 2020</study_first_submitted>
  <study_first_submitted_qc>January 5, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">January 6, 2021</study_first_posted>
  <last_update_submitted>January 5, 2021</last_update_submitted>
  <last_update_submitted_qc>January 5, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">January 6, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Palermo</investigator_affiliation>
    <investigator_full_name>Giuseppe Montalto</investigator_full_name>
    <investigator_title>MD, Full Professor</investigator_title>
  </responsible_party>
  <keyword>cardiovascular risk</keyword>
  <keyword>extracellular vesicles</keyword>
  <keyword>metabolic parameters</keyword>
  <keyword>nutraceuticals</keyword>
  <keyword>Citrus limon (L.)</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Metabolic Syndrome</mesh_term>
    <mesh_term>Syndrome</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

